Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2022-09-06 Transaction in Own Shar…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document explicitly details a 'Disclosure transaction in own shares' occurring between specific dates (29/08/2022 to 02/09/2022). It presents aggregated data on the volume and price of shares acquired/transacted by the issuer (IPSEN). This content directly matches the definition for 'Transaction in Own Shares' (share repurchase/issuance), which corresponds to the filing code POS.
2022-09-06 English
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Disclosure transaction in own shares between 22/08/2022 to 26/08/2022' and provides a detailed table showing the volume and price of shares acquired/transacted by the issuer (IPSEN) over several days. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). Matching Definition: 29. Transaction in Own Shares (Code: POS): Report of the company buying back or selling its own shares (share repurchase/issuance).
2022-08-30 English
Acquisition ou cession des actions de l'émetteur / Transactions sur actions propres (version agrégée)
Transaction in Own Shares Classification · 1% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 22 au 26 Août 2022" (Declaration of transactions on own shares carried out from August 22 to 26, 2022). The content is a detailed table showing the volume and weighted average price of shares transacted by the issuer (IPSEN) on specific dates. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. This matches the 'Transaction in Own Shares' category (POS). The document is a report itself, not an announcement of a report, and its length (2360 chars) is sufficient to contain the data, thus bypassing the RPA/RNS rule.
2022-08-30 French
Acquisition ou cession des actions de l'émetteur / Transactions sur actions propres (version agrégée)
Transaction in Own Shares Classification · 1% confidence The document title is "Déclaration des transactions sur actions propres réalisées du 15 au 19 Août 2022" (Declaration of transactions on own shares carried out from August 15 to 19, 2022). The content is a table detailing the volume, weighted average price, and date of transactions involving the company's own shares (share buybacks or sales). This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance reports.
2022-08-23 French
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
Transaction in Own Shares Classification · 1% confidence The document explicitly details a 'Disclosure transaction in own shares' occurring between specific dates (15/08/2022 to 19/08/2022). It provides a table summarizing the daily volume and weighted average price of shares acquired. This content directly matches the definition for 'Transaction in Own Shares' (share repurchase/issuance), which corresponds to the filing code POS.
2022-08-23 English
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
M&A Activity Classification · 1% confidence The document text is a press release dated August 12, 2022, announcing the finalization of Ipsen's acquisition of Epizyme, Inc. It details the terms of the transaction, the assets acquired (Tazverik® and EZM0414), and includes standard forward-looking statements and company information. This type of announcement, concerning a major corporate transaction like an acquisition, is best classified as a Capital/Financing Update (CAP) as it directly relates to a significant change in the company's structure and financing/asset base, or potentially a Regulatory Filing (RNS) if it were a generic disclosure. However, given the specific focus on the completion of a major financial transaction (acquisition for $1.45 per share plus a CVG), 'CAP' is the most precise fit among the provided options, as it covers financing activities and capital structure changes. It is not an ER, IR, 10-K, or a simple announcement of a report (RPA/RNS).
2022-08-12 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.